Thursday, 4th of April 2024, 20:00
RONEXPRIM, together with the external partner, Malvern Panalytical, have the pleasure to invite you to participate at the webinar:
Key considerations for characterizing LNPs
Lipid Nanoparticles (LNPs) are the most common vector being used in the development of nucleic acid-based gene therapies and vaccines. This webinar highlights the key considerations for LNP development, including LNP structure, formulation parameters, and the function of each lipid component.
We will discuss the common and advanced analytics used to characterize LNPs, what physicochemical properties are measured, and how these properties relate to LNP critical quality attributes.
Finally, we will review several key publications that demonstrate the relationship between LNP physicochemical properties and functional assays to determine immunogenicity and long term stability.
We will discuss the common and advanced analytics used to characterize LNPs, what physicochemical properties are measured, and how these properties relate to LNP critical quality attributes.
Finally, we will review several key publications that demonstrate the relationship between LNP physicochemical properties and functional assays to determine immunogenicity and long term stability.
What you will learn?
• Common and advanced analytics used to characterize LNPs
• What physicochemical properties are measured and how these properties relate to LNP critical quality attributes
• What physicochemical properties are measured and how these properties relate to LNP critical quality attributes
• We'll review several key publications that demonstrate the relationship between LNP physicochemical properties
and functional assays to determine immunogenicity and long term stability
Speakers:
• Jonathan Mehtala - Team Leader Biologics Development, Malvern Panalytical
and functional assays to determine immunogenicity and long term stability
Who should attend?
Any scientist involved in the development of LNP-based therapeutics, including LNP formulation scientists, LNP analytical development scientists, and LNP discovery scientists.
Speakers:
• Jonathan Mehtala - Team Leader Biologics Development, Malvern Panalytical